Nonclinical Dose Formulation: Out of Specification Investigations

Troy Appleton; Peter Bryan; Denise Contos; Teresa R. Henry; Paul Lehmann; Susan Ohorodnik; Dave Reed; Chantal Robichaud; John Schetter; Natalie South; John Weissmann; Monica Lee Whitmire

doi:10.1208/s12248-012-9347-4

by Troy Appleton, Peter Bryan, Denise Contos, Teresa R. Henry, Paul Lehmann, Susan Ohorodnik, Dave Reed, Chantal Robichaud, John Schetter, Natalie South, John Weissmann, Monica Lee Whitmire

Published in AAPS Journal by American Association of Pharmaceutical Scientists (AAPS).

2012 Volume 14, p523-529

Archived Files and Locations

application/pdf 155.2 kB
file_relhzwlsl5a2pnsljslvkt25ii link.springer.com (publisher)
web.archive.org (webarchive)

Read Archived PDF

Preserved and Accessible

Type article-journal
Stage

published

Date 2012-05-08
Language en ^?

DOI 10.1208/s12248-012-9347-4
PubMed 22566150
PMC PMC3385838
Wikidata Q36065597

Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L: 1550-7416

Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)

Cite This

BibTeX
CSL-JSON
MLA
Harvard

Lookup Links

oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar

Catalog Record
Revision: 54d94728-38a6-4f70-8e6c-95e71e42a320
API URL: JSON

Edit Metadata View History

Nonclinical Dose Formulation: Out of Specification Investigations release_dh3lxutaavbtbg46xsoicdkqxq

Archived Files and Locations

Nonclinical Dose Formulation: Out of Specification Investigations `release_dh3lxutaavbtbg46xsoicdkqxq`